Bloomios, a manufacturer and wholesale supplier of hemp-derived CBD supplements and cosmetic products, announced that the U.S. Securities and Exchange Commission (SEC) declared its registration statement on Form S-1 effective on Jan. 26, 2022. The Form S-1 includes audited financials from the years ending Dec. 31, 2019 and Dec. 31, 2020 and enables the company to raise up to $6.5 million to fuel the growth of the company.
This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities.
Bloomios, headquartered in Santa Barbara, Calif. with its operations in Daytona Beach, Fla., provides services including custom formulation, brand development and order fulfillment to a wide variety of customers, including small and major brands, chain stores, vape shops and distributors. It offers its private-label and white-label customers large collections of customizable hemp products that include over 220 products across 12 categories in addition to custom formulation and manufacturing services.